Preliminary reports show conolidine may perhaps inhibit certain ion channels, cutting down neuronal excitability and limiting discomfort indicators. This mechanism is particularly appropriate in neuropathic ache, where abnormal signaling will cause persistent soreness. Also, conolidine appears to affect G protein-coupled receptor (GPCR) pathways in